These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 35163450)

  • 1. Roles of α-Synuclein and Disease-Associated Factors in
    Suzuki M; Sango K; Nagai Y
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.
    Sakai R; Suzuki M; Ueyama M; Takeuchi T; Minakawa EN; Hayakawa H; Baba K; Mochizuki H; Nagai Y
    PLoS One; 2019; 14(6):e0218261. PubMed ID: 31242217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal accumulation of lipid droplets in neurons induces the conversion of alpha-Synuclein to proteolytic resistant forms in a Drosophila model of Parkinson's disease.
    Girard V; Jollivet F; Knittelfelder O; Celle M; Arsac JN; Chatelain G; Van den Brink DM; Baron T; Shevchenko A; Kühnlein RP; Davoust N; Mollereau B
    PLoS Genet; 2021 Nov; 17(11):e1009921. PubMed ID: 34788284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPS35 dysfunction impairs lysosomal degradation of α-synuclein and exacerbates neurotoxicity in a Drosophila model of Parkinson's disease.
    Miura E; Hasegawa T; Konno M; Suzuki M; Sugeno N; Fujikake N; Geisler S; Tabuchi M; Oshima R; Kikuchi A; Baba T; Wada K; Nagai Y; Takeda A; Aoki M
    Neurobiol Dis; 2014 Nov; 71():1-13. PubMed ID: 25107340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Lipids in the Pathogenesis of Parkinson's Disease.
    Kamano S; Ozawa D; Ikenaka K; Nagai Y
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of the α-synuclein expression promotes slowing down early neuropathology development in the
    Golomidov IM; Latypova EM; Ryabova EV; Bolshakova OI; Komissarov AE; Sarantseva SV
    J Neurogenet; 2022 Mar; 36(1):1-10. PubMed ID: 35467466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphatidylinositol-3,4,5-trisphosphate interacts with alpha-synuclein and initiates its aggregation and formation of Parkinson's disease-related fibril polymorphism.
    Choong CJ; Aguirre C; Kakuda K; Beck G; Nakanishi H; Kimura Y; Shimma S; Nabekura K; Hideshima M; Doi J; Yamaguchi K; Nakajima K; Wadayama T; Hayakawa H; Baba K; Ogawa K; Takeuchi T; Badawy SMM; Murayama S; Nagano S; Goto Y; Miyanoiri Y; Nagai Y; Mochizuki H; Ikenaka K
    Acta Neuropathol; 2023 May; 145(5):573-595. PubMed ID: 36939875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucocerebrosidase deficiency accelerates the accumulation of proteinase K-resistant α-synuclein and aggravates neurodegeneration in a Drosophila model of Parkinson's disease.
    Suzuki M; Fujikake N; Takeuchi T; Kohyama-Koganeya A; Nakajima K; Hirabayashi Y; Wada K; Nagai Y
    Hum Mol Genet; 2015 Dec; 24(23):6675-86. PubMed ID: 26362253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinson's Disease Associated α-Synuclein Familial Mutants Promote Dopaminergic Neuronal Death in Drosophila melanogaster.
    Mohite GM; Dwivedi S; Das S; Kumar R; Paluri S; Mehra S; Ruhela N; S A; Jha NN; Maji SK
    ACS Chem Neurosci; 2018 Nov; 9(11):2628-2638. PubMed ID: 29906099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-Synuclein pathology in Drosophila melanogaster is exacerbated by haploinsufficiency of Rop: connecting STXBP1 encephalopathy with α-synucleinopathies.
    Matsuoka T; Yoshida H; Kasai T; Tozawa T; Iehara T; Chiyonobu T
    Hum Mol Genet; 2024 Jul; 33(15):1328-1338. PubMed ID: 38692286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons.
    Zambon F; Cherubini M; Fernandes HJR; Lang C; Ryan BJ; Volpato V; Bengoa-Vergniory N; Vingill S; Attar M; Booth HDE; Haenseler W; Vowles J; Bowden R; Webber C; Cowley SA; Wade-Martins R
    Hum Mol Genet; 2019 Jun; 28(12):2001-2013. PubMed ID: 30753527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of α-synuclein in vitro aggregation kinetics by its alternative splice isoforms.
    Röntgen A; Toprakcioglu Z; Tomkins JE; Vendruscolo M
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2313465121. PubMed ID: 38324572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How can rAAV-α-synuclein and the fibril α-synuclein models advance our understanding of Parkinson's disease?
    Volpicelli-Daley LA; Kirik D; Stoyka LE; Standaert DG; Harms AS
    J Neurochem; 2016 Oct; 139 Suppl 1(Suppl 1):131-155. PubMed ID: 27018978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yeast red pigment modifies cloned human α-synuclein pathogenesis in Parkinson disease models in Saccharomyces cerevisiae and Drosophila melanogaster.
    Nevzglyadova OV; Mikhailova EV; Artemov AV; Ozerova YE; Ivanova PA; Golomidov IM; Bolshakova OI; Zenin VV; Kostyleva EI; Soidla TR; Sarantseva SV
    Neurochem Int; 2018 Nov; 120():172-181. PubMed ID: 30099122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative proteomics of a presymptomatic A53T alpha-synuclein Drosophila model of Parkinson disease.
    Xun Z; Sowell RA; Kaufman TC; Clemmer DE
    Mol Cell Proteomics; 2008 Jul; 7(7):1191-203. PubMed ID: 18353766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Exposure to Paraquat Induces Alpha-Synuclein Pathogenic Modifications in
    Arsac JN; Sedru M; Dartiguelongue M; Vulin J; Davoust N; Baron T; Mollereau B
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribose-cysteine and levodopa abrogate Parkinsonism via the regulation of neurochemical and redox activities in alpha-synuclein transgenic
    Idowu OK; Oremosu AA; Dosumu OO; Mohammed AA
    Fly (Austin); 2024 Dec; 18(1):2306687. PubMed ID: 38286464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Throughput Sequencing Identifies MicroRNAs Mediating α-Synuclein Toxicity by Targeting Neuroactive-Ligand Receptor Interaction Pathway in Early Stage of Drosophila Parkinson's Disease Model.
    Kong Y; Liang X; Liu L; Zhang D; Wan C; Gan Z; Yuan L
    PLoS One; 2015; 10(9):e0137432. PubMed ID: 26361355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omics Analyses in a Neural Stem Cell Model of Familial Parkinson's Disease.
    Notopoulou S; Gkekas I; Petrakis S
    Adv Exp Med Biol; 2023; 1423():149-160. PubMed ID: 37525039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.